R10256 |
Blu9931 |
BLU9931 是一种有效的,高度选择性的,不可逆的成纤维细胞生长因子受体 4 (FGFR4) 抑制剂,其 IC50 值为 3 nM,Kd 值为 6 nM。BL
|
R10258 |
Sofosbuvir;PSI-7977; GS7977 |
Sofosbuvir (PSI-7977) 是 HCV RNA复制抑制剂,EC50 为92 nM。
|
R10259 |
AG490 |
AG-490 (Tyrphostin B42) is an inhibitor of EGFR with IC50 of 0.1 μM in cell-free
|
R10260 |
Sotagliflozin; LP802034; LX4211 |
Sotagliflozin (LX-4211) 是SGLT1/2抑制剂,是抗糖尿病剂。
|
R10261 |
CDC0032 Intermediate |
|
R10262 |
LY294002 |
LY294002 is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of
|
R10264 |
RO3280 |
Ro3280 是一种有效的,高度选择性的 PLK1 抑制剂,IC50 和 Kd 值分别为 3 nM 和 0.09 nM,对 PLK2 和 PLK3 几乎没作用。
|
R10266 |
GlyH101;GlyH-101 |
GlyH-101是可渗透入细胞的CFTR阻断剂,Ki为1.4 uM。
|
R10268 |
KN93;KN-93 |
KN-93是可渗透细胞,可逆和竞争性的抑制剂钙调蛋白依赖性激酶II型 (CaMKII) 抑制剂,Ki 为370 nM。
|
R10269 |
FG-2216 (Synonyms: IOX3; YM311) |
FG-2216 (IOX3; YM311) 是 HIF-PHD 抑制剂,IC50 值为 3.9 uM。
|
R10270 |
GSK2801 |
GSK2801 是一种有效的,选择性的,口服活性的和细胞活性的乙酰赖氨酸竞争性 BAZ2A 和 BAZ2B 溴结构域抑制剂,Kd 值分别为 136 nM 和 2
|
R10271 |
BI 2536;BI2536 |
BI 2536 是 PLK1 和 BRD4 的双抑制剂,IC50 分别为 0.83 和 25 nM。BI-2536 抑制 IFNB (IFN-β,干扰素 β)
|
R10272 |
Lersivirine(UK-453061) |
Lersivirine(UK-453061)是非核苷逆转录酶抑制剂(NNRTI),IC50为119 nM,对野生型和NNRTI抗性型毒株都有效。
|
R10273 |
G007-LK |
G007-LK 是一种有效的,选择性的 TNKS1 和 TNKS2 抑制剂,IC50值分别为 46 nM 和 25 nM。
|
R10274 |
Piperlongumine |
Piperlongumine, a natural alkaloid from Piper longum L., increases the level of
|
R10275 |
Omarigliptin; MK3102 Intermediate1 |
Omarigliptin(MK-3102) is a potent, selective and long-acting DPP-4 inhibitor wit
|
R10276 |
Omarigliptin; MK3102 Intermediate2 |
Omarigliptin(MK-3102) is a potent, selective and long-acting DPP-4 inhibitor wit
|
R10277 |
AZD9291Intermediate3 |
Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
|
R10278 |
AZD9291Intermediate4 |
Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
|
R10279 |
AZD9291Intermediate5 |
Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
|
R10280 |
CAL101 Intermediate1 |
CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM
|
R10281 |
CAL101 Intermediate2 |
CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM
|
R10282 |
CAL101 Intermediate3 |
CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM
|
R10283 |
Nintedanib esylate; BIBF1120 esylate |
Nintedanib esylate (BIBF 1120 esylate) 是一种有效的 VEGFR1/2/3,FGFR1/2/3 和&n
|
R10284 |
Nintedanib; BIBF1120 Intermediate2 |
Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3,
|